Abstract
Perturbation of the equilibrium between human immunodeficiency virus type 1 (HIV-1) and the infected host by administering antiretroviral agents has revealed the rapid turnover of both viral particles and productively infected cells. In this study, we used the infusion of simian immunodeficiency virus (SIV) particles into rhesus macaques to obtain a more accurate estimate of viral clearance in vivo. Consistently, exogenously infused virions were cleared from plasma with an extremely short half-life, on the order of minutes (a mean of 3.3 min). This new estimate is approximately 100-fold lower than the upper bound of 6 h previously reported for HIV-1 in infected humans. In select animals, multiple tissues were collected at the completion of each experiment to track the potential sites of virion clearance. Detectable levels of SIV RNA were found in lymph nodes, spleen, lungs, and liver, but not in other tissues examined. However, only approximately 1 to 10% or less of the infused virions were accounted for by the thorough tissue sampling, indicating that the vast majority of the infused particles must have been degraded over a short period of time. Should the rapid clearance of virions described here be applicable to infected patients, then HIV-1 production and thus the number of productively infected CD4(+) T lymphocytes or the viral burst size must be proportionally higher than previous minimal estimates.
MeSH Terms
Animals
Female
HIV-1/physiology
Half-Life
Humans
Macaca mulatta
Male
RNA, Viral/blood
Simian Immunodeficiency Virus/physiology
Viremia/virology
Virion/physiology
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Zhang L
Aaron Diamond AIDS Research Center, The Rockefeller University, New York, New York, USA.
Dailey P J
He T
Gettie A
Bonhoeffer S
Perelson A S
Ho D D
References (28)
28 references, click to expand
-
Dynamics of HIV-1 and CD4+ lymphocytes in vivo.
AIDS. 1997;11 Suppl A:S17-24
PMID: 9451962
-
Rift Valley Fever virus in mice. II. Adsorption and multiplication of virus.
Br J Exp Pathol. 1956 Apr;37(2):110-9
PMID: 13315886
-
Role of the mononuclear phagocyte system in the immunopathogenesis of human immunodeficiency virus infection and the acquired immunodeficiency syndrome.
Rev Infect Dis. 1988 Nov-Dec;10(6):1142-54
PMID: 3206059
-
Blood clearance of P32-labeled vesicular stomatitis and Newcastle disease viruses by the reticuloendothelial system in mice.
J Immunol. 1960 Jul;85:99-105
PMID: 13805345
-
The response of mice to large intravenous injections of ectromelia virus. I. The fate of injected virus.
Br J Exp Pathol. 1959 Dec;40:533-42
PMID: 14422711
-
Human immunodeficiency virus causes mononuclear phagocyte dysfunction.
Proc Natl Acad Sci U S A. 1990 May;87(10):3933-7
PMID: 2187195
-
Experimental infection of monkeys with Langat virus. II. Turnover of circulating virus.
Am J Epidemiol. 1967 May;85(3):494-502
PMID: 4960867
-
Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection.
Science. 1997 May 9;276(5314):960-4
PMID: 9139661
-
Role of the mononuclear phagocyte system in the development of acquired immunodeficiency syndrome (AIDS).
J Leukoc Biol. 1988 Jan;43(1):91-7
PMID: 3275735
-
HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time.
Science. 1996 Mar 15;271(5255):1582-6
PMID: 8599114
-
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.
Nature. 1995 Jan 12;373(6510):123-6
PMID: 7816094
-
Antigens pre-bound to the primate erythrocyte complement receptor via cross-linked bispecific monoclonal antibody heteropolymers are rapidly cleared from the circulation.
Eur J Immunol. 1993 Nov;23(11):3021-7
PMID: 8223879
-
Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo.
J Immunol. 1996 Aug 15;157(4):1791-8
PMID: 8759769
-
The response of mice to the intravenous injection of cowpox virus.
Br J Exp Pathol. 1968 Feb;49(1):24-32
PMID: 5689130
-
Demonstration of defective C3-receptor-mediated clearance by the reticuloendothelial system in patients with acquired immunodeficiency syndrome.
J Clin Invest. 1987 Mar;79(3):715-20
PMID: 3546375
-
Immune complexes bound to the primate erythrocyte complement receptor (CR1) via anti-CR1 mAbs are cleared simultaneously with loss of CR1 in a concerted reaction in a rhesus monkey model.
Clin Immunol Immunopathol. 1997 Jan;82(1):49-59
PMID: 9000042
-
Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection.
Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1154-9
PMID: 9448301
-
RELATIONSHIP BETWEEN BLOOD CLEARANCE AND VIRURIA AFTER INTRAVENOUS INJECTION OF MICE AND RATS WITH BACTERIOPHAGE AND POLIOVIRUSES.
J Immunol. 1965 Jun;94:833-41
PMID: 14321426
-
Neutralization of human immunodeficiency virus type 1 by complement occurs by viral lysis.
J Virol. 1990 Dec;64(12):5869-73
PMID: 1700828
-
Bispecific monoclonal antibody complexes bound to primate erythrocyte complement receptor 1 facilitate virus clearance in a monkey model.
J Immunol. 1997 Jan 15;158(2):842-50
PMID: 8993002
-
Tracking of dye-labeled lymphocytes in rhesus macaques.
J Med Primatol. 1996 Apr;25(2):112-21
PMID: 8864982
-
The response of mice to large intravenous injections of ectromelia virus. II. The growth of virus in the liver.
Br J Exp Pathol. 1959 Dec;40:543-50
PMID: 14422712
-
Perspectives series: host/pathogen interactions. Dynamics of HIV-1 replication in vivo.
J Clin Invest. 1997 Jun 1;99(11):2565-7
PMID: 9169484
-
Decay characteristics of HIV-1-infected compartments during combination therapy.
Nature. 1997 May 8;387(6629):188-91
PMID: 9144290
-
Effects of (R)-9-(2-phosphonylmethoxypropyl)adenine monotherapy on chronic SIV infection in macaques.
AIDS Res Hum Retroviruses. 1997 May 20;13(8):707-12
PMID: 9168239
-
Role of complement and Fc receptors in the pathogenesis of HIV-1 infection.
Springer Semin Immunopathol. 1997;18(3):371-90
PMID: 9089955
-
Viral dynamics in human immunodeficiency virus type 1 infection.
Nature. 1995 Jan 12;373(6510):117-22
PMID: 7529365
-
Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection.
J Virol. 1997 Oct;71(10):7518-25
PMID: 9311831